CLASSIC HODGKIN LYMPHOMA
Clinical trials for CLASSIC HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for CLASSIC HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for frail hodgkin patients: immunotherapy plus chemo
Disease control Recruiting nowThis study tests a combination of the immunotherapy drug pembrolizumab and three chemotherapy drugs in 23 frail patients newly diagnosed with Hodgkin lymphoma who cannot receive standard treatment. The goal is to see if this approach can safely shrink or eliminate cancer. Partici…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 01, 2026 15:58 UTC
-
Blood test may allow safer, lighter chemo for hodgkin lymphoma patients
Disease control Recruiting nowThis study tests whether a simple blood test that measures tumor DNA can help doctors safely reduce the amount of chemotherapy for people with advanced Hodgkin lymphoma. About 125 participants will receive either fewer or standard chemotherapy cycles based on their blood test res…
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC
-
Blood clues could predict heart trouble in hodgkin survivors
Knowledge-focused Recruiting nowThis study looks at 190 Hodgkin lymphoma survivors to see if certain blood cell changes (called clonal hematopoiesis) are linked to heart problems later in life. Participants must have had chemotherapy as children or teens. The goal is to find out who is at higher risk for heart …
Matched conditions: CLASSIC HODGKIN LYMPHOMA
Sponsor: Children's Oncology Group • Aim: Knowledge-focused
Last updated Apr 30, 2026 15:50 UTC